ImmunityBio, Inc. 8-KCurrent Reports (8-K / ad hoc)

Changes / Accountants

Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description of Exhibit 99.1* Press Release dated October 14, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * Furnished herewith. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IMMUNITYBIO, INC. Registrant Date: October 14, 2026 By: /s/ David C. Sachs David C. Sachs Chief Financial Officer